{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:11:42Z","timestamp":1757617902219,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12149-025-02048-1","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:37:56Z","timestamp":1745822276000},"page":"781-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation study on accuracy of our newly proposed methods for post-therapeutic liver reserve capacity estimation utilizing 99 mTc-GSA scintigraphy prior to carbon-ion radiotherapy"],"prefix":"10.1007","volume":"39","author":[{"given":"Kana","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-4737","authenticated-orcid":false,"given":"Tatsuya","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamasa","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"2048_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12885-024-12154-4","volume":"24","author":"T Kaneko","year":"2024","unstructured":"Kaneko T, Makishima H, Wakatsuki M, Hiroshima Y, Matsui T, Yasuda S, et al. Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study. BMC Cancer. 2024;24:383. https:\/\/doi.org\/10.1186\/s12885-024-12154-4.","journal-title":"BMC Cancer"},{"key":"2048_CR2","doi-asserted-by":"publisher","first-page":"14004","DOI":"10.1002\/cam4.6046","volume":"12","author":"Y Hiroshima","year":"2023","unstructured":"Hiroshima Y, Wakatsuki M, Kaneko T, Makishima H, Okada NN, Yasuda S, et al. Clinical impact of carbon-ion radiotherapy on hepatocellular carcinoma with Child-Pugh B cirrhosis. Cancer Med. 2023;12:14004\u201314.","journal-title":"Cancer Med"},{"key":"2048_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101063","volume":"6","author":"P Hoegen-Sa\u00dfmannshausen","year":"2024","unstructured":"Hoegen-Sa\u00dfmannshausen P, Naumann P, Hoffmeister-Wittmann P, Ben Harrabi S, Seidensaal K, Weykamp F, et al. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial. JHEP Rep. 2024;6: 101063. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101063.","journal-title":"JHEP Rep"},{"key":"2048_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3350\/cmh.2023.0217","volume":"29","author":"HK Byun","year":"2023","unstructured":"Byun HK, Kim C, Seong J. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma. Clin Mol Hepatol. 2023;29:945\u201357.","journal-title":"Clin Mol Hepatol"},{"key":"2048_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12885-017-3724-4","volume":"17","author":"S Shiba","year":"2017","unstructured":"Shiba S, Abe T, Shibuya K, Katoh H, Koyama Y, Shimada H, et al. Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma. BMC Cancer. 2017;17:721. https:\/\/doi.org\/10.1186\/s12885-017-3724-4.","journal-title":"BMC Cancer"},{"key":"2048_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13014-020-01634-z","volume":"15","author":"S Shiba","year":"2020","unstructured":"Shiba S, Shibuya K, Okamoto M, Okazaki S, Komatsu S, Kubota Y, et al. Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma. Radiat Oncol. 2020;15:195. https:\/\/doi.org\/10.1186\/s13014-020-01634-z.","journal-title":"Radiat Oncol"},{"key":"2048_CR7","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1111\/liv.13969","volume":"38","author":"K Shibuya","year":"2018","unstructured":"Shibuya K, Ohno T, Terashima K, Toyama S, Yasuda S, Tsuji H, et al. Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study. Liver Int. 2018;38:2239\u201347.","journal-title":"Liver Int"},{"key":"2048_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF02439544","volume":"24","author":"SK Ha-Kawa","year":"1997","unstructured":"Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med. 1997;24:130\u20137.","journal-title":"Eur J Nucl Med"},{"key":"2048_CR9","first-page":"2233","volume":"32","author":"SK Ha-Kawa","year":"1991","unstructured":"Ha-Kawa SK, Tanaka Y. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med. 1991;32:2233\u201340.","journal-title":"J Nucl Med"},{"key":"2048_CR10","first-page":"426","volume":"25","author":"AH Kwon","year":"1997","unstructured":"Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426\u20139.","journal-title":"Hepatology"},{"key":"2048_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247675","volume":"16","author":"K Tomita","year":"2021","unstructured":"Tomita K, Chiba N, Ochiai S, Gunji T, Hikita K, Kobayashi T, et al. Prognostic value of future liver remnant LU15 index of 99mTc-galactosyl serum albumin scintigraphy for predicting posthepatectomy liver failure. PLoS ONE. 2021;16: e0247675. https:\/\/doi.org\/10.1371\/journal.pone.0247675.","journal-title":"PLoS ONE"},{"key":"2048_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2214\/AJR.17.18411","volume":"210","author":"A Kato","year":"2018","unstructured":"Kato A, Nakamoto Y, Ishimori T, Seo S, Uemoto S, Togashi K. Predictability of 99mTc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure. AJR Am J Roentgenol. 2018;210:158\u201365.","journal-title":"AJR Am J Roentgenol"},{"key":"2048_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/RLU.0000000000001913","volume":"43","author":"Y Mizutani","year":"2018","unstructured":"Mizutani Y, Hirai T, Nagamachi S, Nanashima A, Yano K, Kondo K, et al. Prediction of Posthepatectomy liver failure proposed by the international study group of liver surgery: residual liver function estimation with 99mTc-galactosyl human serum albumin scintigraphy. Clin Nucl Med. 2018;43:77\u201381.","journal-title":"Clin Nucl Med"},{"key":"2048_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3892\/or.2014.3691","volume":"33","author":"H Nishikawa","year":"2015","unstructured":"Nishikawa H, Osaki Y, Komekado H, Sakamoto A, Saito S, Nishijima N, et al. Clinical implication of the preoperative GSA index in 99mTc-GSA scintigraphy in hepatitis C virus-related hepatocellular carcinoma. Oncol Rep. 2015;33:1071\u20138.","journal-title":"Oncol Rep"},{"key":"2048_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11604-011-0041-8","volume":"30","author":"M Yoshida","year":"2012","unstructured":"Yoshida M, Shiraishi S, Sakaguchi F, Utsunomiya D, Tashiro K, Tomiguchi S, et al. Fused 99m-Tc-GSA SPECT\/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve? Jpn J Radiol. 2012;30:255\u201362.","journal-title":"Jpn J Radiol"},{"key":"2048_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00259-022-05985-5","volume":"50","author":"K Yamazaki","year":"2023","unstructured":"Yamazaki K, Nishii R, Mizutani Y, Makishima H, Kaneko T, Isobe Y, et al. Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors. Eur J Nucl Med Mol Imaging. 2023;50:581\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2048_CR17","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/s41598-022-06713-7","volume":"12","author":"YI Park","year":"2022","unstructured":"Park YI, Choi SH, Hong CS, Cho MS, Son J, Jang JW, et al. A pilot study of a novel method to visualize three-dimensional dose distribution on skin surface images to evaluate radiation dermatitis. Sci Rep. 2022;12:2729. https:\/\/doi.org\/10.1038\/s41598-022-06713-7.","journal-title":"Sci Rep"},{"key":"2048_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00006231-200305000-00004","volume":"24","author":"N Shuke","year":"2003","unstructured":"Shuke N, Aburano T, Okizaki A, Zhao C, Nakajima K, Yokoyama K, et al. Estimation of fractional liver uptake and blood retention of 99mTc-DTPA-galactosyl human serum albumin: an application of a simple graphical method to dynamic SPECT. Nucl Med Commun. 2003;24:503\u201311.","journal-title":"Nucl Med Commun"},{"key":"2048_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100775","volume":"6","author":"M Ebara","year":"2021","unstructured":"Ebara M, Shibuya K, Shimada H, Kawashima M, Hirasawa H, Taketomi-Takahashi A, et al. Evaluation of threshold dose of damaged hepatic tissue after carbon-ion radiation therapy using Gd-EOB-DTPA-enhanced magnetic resonance imaging. Adv Radiat Oncol. 2021;6: 100775. https:\/\/doi.org\/10.1016\/j.adro.2021.100775.","journal-title":"Adv Radiat Oncol"},{"key":"2048_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.adro.2019.09.007","volume":"5","author":"S Yasuda","year":"2019","unstructured":"Yasuda S, Kato H, Imada H, Isozaki Y, Kasuya G, Makishima H, et al. Long-term results of high-dose 2-fraction carbon ion radiation therapy for hepatocellular carcinoma. Adv Radiat Oncol. 2019;5:196\u2013203.","journal-title":"Adv Radiat Oncol"},{"key":"2048_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.prro.2016.10.003","volume":"7","author":"DAS Toesca","year":"2017","unstructured":"Toesca DAS, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. Pract Radiat Oncol. 2017;7:173\u201382.","journal-title":"Pract Radiat Oncol"},{"key":"2048_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MNM.0000000000000950","volume":"40","author":"Y Tanoue","year":"2019","unstructured":"Tanoue Y, Nanashima A, Yano K, Fujii Y, Hiyoshi M, Imamura N, et al. Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver. Nucl Med Commun. 2019;40:145\u201352.","journal-title":"Nucl Med Commun"},{"key":"2048_CR23","doi-asserted-by":"crossref","unstructured":"Tsuruga Y, Kamiyama T, Kamachi H, Shimada S, Wakayama K, Orimo Tatsuya, et al. Significance of functional hepatic resection rate calculated using 3D CT\/99mTc-galactosyl human serum albumin single-photon emission computed tomography fusion imaging. World J Gastroenterol. 2016;22:4373\u20139.","DOI":"10.3748\/wjg.v22.i17.4373"},{"key":"2048_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12149-011-0520-0","volume":"25","author":"M Kaibori","year":"2011","unstructured":"Kaibori M, Ha-Kawa SK, Maehara M, Ishizaki M, Matsui K, Sawada S, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med. 2011;25:593\u2013602.","journal-title":"Ann Nucl Med"},{"key":"2048_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s12149-010-0426-2","volume":"24","author":"H Wakamatsu","year":"2010","unstructured":"Wakamatsu H, Nagamachi S, Kiyohara S, Fujita S, Kamimura K, Futami S, et al. Predictive value of Tc-99m galactosyl human serum albumin liver SPECT on the assessment of functional recovery after partial hepatectomy: a comparison with CT volumetry. Ann Nucl Med. 2010;24:729\u201334.","journal-title":"Ann Nucl Med"},{"key":"2048_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4329\/wjr.v6.i8.598","volume":"6","author":"S Shirai","year":"2014","unstructured":"Shirai S, Sato M, Noda Y, Kumayama Y, Shimizu N. Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy. World J Radiol. 2014;6:598\u2013666.","journal-title":"World J Radiol"},{"key":"2048_CR27","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.3390\/cancers3044114","volume":"3","author":"S Shirai","year":"2011","unstructured":"Shirai S, Sato M, Noda Y, Kishi K, Kawai N, Minamiguchi H, et al. Distribution of functional liver volume in hepatocellular carcinoma patients with portal vein tumor thrombus in the 1st branch and main trunk using single photon emission computed tomography-application to radiation therapy. Cancers. 2011;3:4114\u201326.","journal-title":"Cancers"},{"key":"2048_CR28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ijrobp.2009.03.023","volume":"76","author":"S Shirai","year":"2010","unstructured":"Shirai S, Sato M, Suwa K, Kishi K, Shimono C, Sonomura T, et al. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys. 2010;76:1037\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2048_CR29","doi-asserted-by":"publisher","first-page":"155932581983214","DOI":"10.1177\/1559325819832149","volume":"17","author":"R Toya","year":"2019","unstructured":"Toya R, Saito T, Kai Y, Shiraishi S, Matsumiya T, Watakabe T, et al. Impact of 99mTc-GSA SPECT image-guided inverse planning on dose-function histogram parameters for stereotactic body radiation therapy planning for patients with hepatocellular carcinoma: a dosimetric comparison study. Dose Response. 2019;17:1559325819832149. https:\/\/doi.org\/10.1177\/1559325819832149.","journal-title":"Dose Response"},{"key":"2048_CR30","first-page":"1511","volume":"38","author":"R Toya","year":"2018","unstructured":"Toya R, Saito T, Shiraishi S, Kai Y, Murakami R, Matsuyama T, et al. Dose-function histogram evaluation using 99mTc-GSA SPECT\/CT images for stereotactic body radiation therapy planning for hepatocellular carcinoma patients: a dosimetric parameter comparison. Anticancer Res. 2018;38:1511\u20136.","journal-title":"Anticancer Res"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02048-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:29:26Z","timestamp":1757161766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02048-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2048"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02048-1","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}